Long‐Term Danazol Treatment for an Adolescent Girl with Aplastic Anemia

In: Asia-Oceania Journal of Obstetrics and Gynaecology · 1986 · vol. 12(3) , pp. 365–370 · doi:10.1111/j.1447-0756.1986.tb00207.x · PMID:3778317 · W2120783852
article OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex View on PubMed View at publisher
AI-generated summary by claude@2026-06, 2026-06-08

Long-term danazol treatment for four years and ten months suppressed uterine bleeding and normalized hematological findings in an adolescent girl with aplastic anemia, with minimal side effects.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Abstract Danazol was administered for four years and ten months to control uterine bleeding in a 12‐year‐old girl who had had aplastic anemia. During treatment, ovulation was suppressed and the amount of uterine bleeding was much less than that of the usual monthly periods. After 58 months of danazol therapy, all the hematological findings became normal. At present, despite restoration of the normal menstrual cycles, she has normal hematological values without blood transfusions. There were few side effects during the ingestion of danazol. Danazol seems to be effective for the long‐term control of uterine bleeding.

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (13)

Cited by (1)

Source provenance

openalex
last seen: 2026-05-11T03:56:39.559565+00:00
License: CC0 · commercial use OK